Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance

Affiliations

• ¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
• ² Division of Gastroenterology, University of California Irvine, Irvine, CA, USA.
• ³ VA Long Beach Healthcare System, Long Beach, CA, USA.
• ⁴ Liver and Energy Metabolism Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
• ⁵ Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA.
• ⁶ VA San Diego Healthcare System, San Diego, CA, USA.
• ⁷ Division of Endocrinology, Diabetes, and Metabolism, University of Florida, Gainesville, FL, USA.
• ⁸ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
• ⁹ VA Health Services Research and Development Service, Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX, USA.
• ¹⁰ Michael E. DeBakey VA Medical Center, Houston, TX, USA.
• ¹¹ Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Phoenix, AZ, USA.